Amgen (AMGN) FCF Margin (2009 - 2026)

Amgen has reported FCF Margin for 18 years, with the latest figure at 34.7% in Q2 2026.

• On a quarterly basis, FCF Margin rose 1388.0% year-over-year to 34.7% in Q2 2026; TTM through Jun 2026 was 26.71%, a 366.0% decrease from a year earlier, with the FY2025 full-year figure at 22.04%, down 906.0% from the prior year.
• FCF Margin was 34.7% for Q2 2026 at Amgen, up from 17.14% in the prior quarter.
• The five-year high for FCF Margin was 503.05% in Q4 2022, with the low at 3.53% in Q4 2023.
• Average FCF Margin over 5 years is 53.79%, with a median of 29.06% recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: FCF Margin surged 46623 bps in 2022, then tumbled 49952 bps in 2023.
• Over 5 years, FCF Margin stood at 503.05% in 2022, then plunged by 99 bps to 3.53% in 2023, then jumped by 1273 bps to 48.43% in 2024, then tumbled by 80 bps to 9.74% in 2025, then soared by 256 bps to 34.7% in 2026.
• The last three FCF Margin figures came in at 34.7% (Q2 2026), 17.14% (Q1 2026), and 9.74% (Q4 2025), per Business Quant data.